EGOI-PCOS’s application to become a supporting affiliate member of the Italian Federation of Medical-Scientific Societies (FISM) has been accepted, with our official membership starting on January 1, 2025. This strategic partnership reinforces our commitment to advancing scientific research and enhancing clinical care. Through our collaboration with FISM, we aim to amplify our impact on women’s health research and support a multidisciplinary, personalized approach to managing a wide range of health conditions.
About FISM
FISM, established with the vision of creating a cohesive network of medical-scientific societies, plays a pivotal role in the Italian healthcare landscape. FISM’s objectives include promoting collaboration among societies, endorsing high standards of medical education, and advocating for research and innovation in medical sciences. Through their extensive network and resources, FISM is dedicated to advancing knowledge and practices that benefit public health on a national scale.
Partnership with FISM
As a supporting affiliate member, EGOI-PCOS will join a robust network of medical and scientific societies under FISM. This partnership strengthens our ability to collaborate with other scientific communities, fostering the exchange of knowledge and resources essential for advancing healthcare. Through FISM, EGOI-PCOS gains an expanded platform to promote research, share insights, and support ongoing professional education.
Being part of FISM will allow us to actively participate in the numerous events they organize, with opportunities to host dedicated sessions that spotlight our research focus. Additionally, EGOI-PCOS will now be able to seek FISM’s endorsement for our own events, adding valuable recognition and support to our initiatives.
This collaboration aligns seamlessly with FISM’s mission to unify and empower medical-scientific societies in Italy, promoting high healthcare standards and supporting the professional growth of medical experts across various fields.
Looking Ahead
We are excited about the potential this partnership holds to enhance our research on PCOS, advocate for improved patient care, and contribute meaningfully to the advancement of women’s health.